PensionDanmark Pensionsforsikringsaktieselskab 13F: Adds $3.3M to CVS Stake
Key Points
- PensionDanmark grew its position in CVS Health Corporation by 17.3% during the reported period, acquiring 38,052 shares to end with 257,782 shares worth about $22.1 million.
- CVS Health recently traded around $92.69, sitting comfortably above its 50-day and 200-day moving averages while remaining well below its 52-week peak of $110.68.
- Wall Street analysts hold a strong buy consensus on the healthcare provider, with a mean price target of $115.48 ahead of the company's next earnings report on November 4, 2026.
Get CVS Health text alerts
We text you when insiders, Congress, analysts or big funds move on $CVS.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated CVS Health Corporation alert may contain errors. Disclosures
PensionDanmark grew its holdings in CVS Health Corporation (NYSE:CVS) by 17.3% during the quarter, buying an extra 38,052 shares. That move brought the fund's total position to 257,782 shares, which carried a value of about $22.1 million when disclosed in a Form 13F filing with the SEC on October 19, 2026.
CVS
CVS Health Corporation
PensionDanmark Pensionsforsikringsaktieselskab vs. the S&P 500
Hypothetical returns from PensionDanmark Pensionsforsikringsaktieselskab's disclosed trades, not real profit or advice. How we model this.
What Changed in PensionDanmark's CVS Health Position
The fund added 38,052 shares to its portfolio during the period, lifting its total stake to 257,782 shares from 219,730 shares. The resulting investment was valued at $22,089,340 as of the filing date.
Other Institutional Activity in CVS Health
Other large funds have also adjusted their holdings in the healthcare provider. Dodge & Cox Inc. reduced its position by 1,765,644 shares, or 3.4%, ending the period with 50,012,765 shares worth about $4,635,183,075.
CVS Health Corporation Stock Up 0.4%
CVS Health recently traded around $92.69, down about 16.3% from its 52-week high of $110.68 and up 33.3% from its 52-week low of $69.51. The stock closed at $92.68 on October 19, 2026. Shares trade above both the 50-day moving average of $91.80 and the 200-day moving average of $88.12. The company carries a price-to-earnings ratio of 24.36 and a forward price-to-earnings ratio of 10.85.
Recent Earnings
CVS Health generated trailing-twelve-month revenue of $412.65 billion and earnings of $3.80 per share. The healthcare company reported a net profit margin of 1.2% and a return on equity of 6.2%. The company's next financial update is scheduled for November 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
11 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 15.8%. Revenue beat estimates by 4.6%.
-
Profit surprise
EBITDA beat by 15 percent. Operating income beat by 4 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
11 target raises.
-
Earnings quality
Operating margin up 1.1 points. Positive free cash flow.
Earnings Call Summary
CVS delivered a strong first quarter with $100.4 billion in revenue, up 6 percent year over year, and earnings per share of $2.57, beating consensus by 36 cents. The Aetna health insurance business showed major improvement with operating income up 1 billion dollars year over year and a better medical benefit ratio. Pharmacy sales grew 3 percent at existing stores driven by strong prescription volume increases. Management is focused on affordability, reducing friction in the health system, and launching a new consumer app called Health100 powered by artificial intelligence.
Guidance CVS raised full year earnings guidance to $7.30 to $7.50 per share, up from $7.00 to $7.20. They expect at least $405 billion in revenue for the year. Operating cash flow guidance improved to at least $9.5 billion.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Dividend
The company pays an annual dividend with a yield of 2.87% and a payout ratio of 70.0%.
Insider Buying and Selling at CVS Health Corporation
Company insiders have made notable transactions in recent months. Officer Tilak Mandadi sold 69,551 shares on May 8, 2026, at an average price of $89.58, totaling $6,230,379. Director Larry Robbins sold 3,372,000 shares on May 21, 2026, for a total value of $317,471,136.
Analysts Set New Price Targets
Wall Street firms have kept an optimistic outlook on the stock. On August 6, 2026, UBS maintained a Buy rating and raised its price target to $126.00 from $122.00. JP Morgan maintained an Overweight rating on August 12, 2026, lifting its target to $118.00 from $111.00. Argus Research maintained a Buy rating on August 19, 2026, raising its target to $114.00 from $104.00. UBS later adjusted its stance on September 3, 2026, keeping a Buy rating while lowering its target to $118.00 from $126.00. Leerink Partners maintained an Outperform rating on October 12, 2026, moving its target to $112.00 from $119.00. Overall, the stock holds a strong buy consensus rating among 25 analysts.
About CVS Health
CVS Health Corporation operates as a healthcare company providing health insurance, pharmacy services, and medical management plans across the United States. Its operations span retail pharmacies, health care benefits, and prescription drug plans.
Bottom Line
Investors will watch for the company's upcoming earnings report on November 4, 2026, to gauge profit trends and operational progress. Institutional filings will continue to show how large funds manage their positions in the healthcare sector.
Related Filing Alerts
Source: PensionDanmark Pensionsforsikringsaktieselskab's 13F filing on $CVS (Oct 19, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts